miR-34b/HSPG2,FOXO3

Shi Tao1, Qianlei Huang1, Weilun Zhou1

  • 1Department of Hematology, Hainan Province Clinical Medical Center, The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan Province, China.

概括

作为瘤抑制剂的FOXO3在扩散性大B细胞淋巴瘤 (DLBCL) 中被降低. 抑制FOXO3抑制DLBCL细胞的增殖,并通过miR-34b/HSPG2通路促进细胞亡.